Skip to main content

Table 1 Univariate analysis of preoperative factors for postoperative survival in patients with MSCC from NSCLC

From: Prediction of survival prognosis after surgery in patients with symptomatic metastatic spinal cord compression from non-small cell lung cancer

Factors Patients (n) Survival MOS (mo) P
6 mo (%) 12 mo (%)
Age
 ≤ 57 years 34 61 27 7.1 0.16
 ≥ 58 years 30 42 18 4.8
Gender
 Female 22 55 23 6.3 0.90
 Male 42 52 24 6.2
Preoperative ambulatory status
 Ambulatory 33 64 32 8.8 0.003
 Nonambulatory 31 41 14 4.8
Other bone metastases
 No 16 69 21 7.9 0.58
 Yes 48 47 23 4.9
ECOG performance status
 1–2 43 66 29 8.8 <0.001
 3–4 21 26 5 4.5
Number of involved vertebrae
 1–2 36 67 35 7.9 0.001
 ≥ 3 28 36 9 4.4
Visceral metastases
 No 33 78 36 10.8 0.002
 Yes 31 27 10 4.3
Interval from cancer diagnosis to surgery
 ≤ 80 days 32 59 24 7.1 0.73
 > 80 days 32 47 22 5.5
Time developing motor deficits
 ≤ 14 days 30 30 7 3.9 <0.001
 > 14 days 34 72 37 10.8
  1. MSCC indicates metastatic spinal cord compression; NSCLC, non-small cell lung cancer; MOS, median overall survival; MO, months; ECOG, Eastern Cooperative Oncology Group